Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

655

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2010

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

2.5 mg/day - oraly

Trial Locations (53)

Unknown

Novartis Investigative Site, Albstadt

Schorndorf, Augsburg

Novartis Investigative Site, Bamberg

Novartis Investigative Site, Berlin

Novartis Investigative Site, Bonn

Novartis Investigative Site, Bottrop

Novartis Investigative Site, Braunschweig

Novartis Investigative site, Celle

Novartis Investigative Site, Chemnitz

Novartis Investigative Site, Dortmund

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Fulda

Novartis Investigative Site, Gera

Novartis Investigative Site, Gütersloh

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Hamelin

Novartis Investigative Site, Hanover

Novartis Investigative Site, Herne

Novartis Investigative Site, Holzminden

Novartis Investigative Site, Höxter

Novartis Investigative Site, Ilsede

Novartis Investigative Site, Itzehoe

Novartis Investigative Site, Jena

Novartis Investigative Site, Karlsruhe

Novartis Investigative Site, Kempten

Novartis Investigative Site, Konigs

Schorndorf, Konstanz

Novartis Investigative Site, Lich

Novartis Investigative Site, Lohsa/Weisskollm

Novartis Investigative Site, Ludwigsburg

Novartis Investigative Site, Memmingen

Novartis Investigative Site, Mühlhausen

Novartis Investigative Site, München

Novartis Investigative Site, Münster

Novartis Investigative Site, Neumünster

Novartis Investigative Site, Neunkirchen

Novartis Investigative Site, Offenburg

Novartis Investigative Site, Pforzheim

Novartis Investigative Site, Rendsburg

Novartis Investigative Site, Saarbrücken

Novartis Investigative Site, Saarlouis

Novartis Investigative Site, Saint Wendel

Novartis Investigative Site, Salzgitter

Novartis Investigative Site, Schorndorf

Novartis Investigative Site, Schwetzingen

Novartis Investigative Site, Starnberg

Novartis Investigative Site, Stuttgart

Novartis Investigative Site, Tuttlingen

Novartis Investigative Site, Ulm

Novartis Investigative Site, Walsrode

Novartis Investigative Site, Westerburg

Novartis Investigative Site, Wiesbaden

Novartis Investigative Site, Wolfsburg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY